Metraipolis › archive › dc_3d2dabc75a69

Global pharmacovigilance overview of adverse drug reactions associated with propofol: A descriptive pharmacovigilance study using WHO-VigiAccess data — Europe PMC PMID:42601680

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42601680
DOI
10.1097/md.0000000000050189
License (as archived)
solo-consultazione
Archived
2026-10-08T04:16:15.050Z
SHA-256 of the archived text
be08fe60d42e6d4fb112082e8ffd4abab8fa7572e5198bbd5e585b979bf5637d
Stable URL of this page
https://metraipolis.com/documento/dc_3d2dabc75a69

How to cite

Global pharmacovigilance overview of adverse drug reactions associated with propofol: A descriptive pharmacovigilance study using WHO-VigiAccess data — Europe PMC PMID:42601680 — Europe PMC (en), https://europepmc.org/article/MED/42601680 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3d2dabc75a69 (Metraipolis archive dc_3d2dabc75a69, sha256 be08fe60d42e6d4fb112082e8ffd4abab8fa7572e5198bbd5e585b979bf5637d)
BibTeX
@misc{dc3d2dabc75a69,
  title = {Global pharmacovigilance overview of adverse drug reactions associated with propofol: A descriptive pharmacovigilance study using WHO-VigiAccess data — Europe PMC PMID:42601680},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42601680},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3d2dabc75a69; sha256 be08fe60d42e6d4fb112082e8ffd4abab8fa7572e5198bbd5e585b979bf5637d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42601680. Agents can read the archived copy with the MCP tool read_document.